You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2024

SANDOZ INC Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SANDOZ INC, and what generic and branded alternatives to SANDOZ INC drugs are available?

SANDOZ INC has twenty-six approved drugs.

There are nineteen tentative approvals on SANDOZ INC drugs.

Drugs and US Patents for SANDOZ INC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc TOPOTECAN topotecan hydrochloride SOLUTION;INTRAVENOUS 200199-003 Feb 25, 2011 DISCN Yes No ⤷  Subscribe ⤷  Subscribe
Sandoz Inc ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075459-002 Aug 22, 2000 AB RX No No ⤷  Subscribe ⤷  Subscribe
Sandoz Inc ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 201047-001 Jun 6, 2012 AB RX No No ⤷  Subscribe ⤷  Subscribe
Sandoz Inc ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075459-001 Aug 22, 2000 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.